In 2023, the trade exchange (includes international purchases and sales) of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned was US$502M.
In 2023, the states with the most international sales in Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned were Ciudad de México (US$60M), Chihuahua (US$23.9M), Baja California (US$22.7M), Jalisco (US$17.4M), and Sonora (US$14.8M).
The states with the most international purchases in 2023 were Ciudad de México (US$244M), Tamaulipas (US$33.6M), Baja California (US$22.1M), Chihuahua (US$17.8M), and Jalisco (US$13.1M).
In 2023, the main commercial destinations of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned were United States (US$89.5M), Argentina (US$17.3M), Brazil (US$10.9M), Colombia (US$7.55M), and Panama (US$6.45M).
The main commercial origins of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned in 2023 were United States (US$96.6M), Finland (US$61.5M), Germany (US$55M), Netherlands (US$21.8M), and Ireland (US$21M).
In the global context, the main exporting countries of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned in 2022 were Germany (US$3.31B), United States (US$2.16B), and Netherlands (US$1.47B). In the same year, the main importing countries of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned were United States (US$3.74B), Germany (US$1.34B), and Belgium (US$1.14B).